RenaCare Dialysis Clinic – Business Plan
Investment-grade business plan for RenaCare Dialysis Clinic (Pty) Ltd — an R20-million raise to launch a 20-station specialist renal-care facility serving CKD and ESRD patients in South Africa, scaling to R57.9 million revenue by Year 5 at a 28.7% equity IRR.
Confidential Business Plan
RenaCare Dialysis Clinic
A specialist renal-care facility offering in-centre haemodialysis and peritoneal dialysis to South Africans living with chronic kidney disease and end-stage renal disease — launching with a 20-station flagship clinic and a replication pathway across Johannesburg, Pretoria and Cape Town, structured as an investment-grade R20-million opportunity for investors, lenders and strategic partners.
Chronic kidney disease and end-stage renal disease are rising steeply in South Africa, yet treated dialysis capacity falls well short of demand — a structural, recession-resilient shortfall in a medical-aid-funded specialty. RenaCare addresses it with a 20-station flagship clinic running three shifts a day, rigorous clinical governance and a clear multi-city replication pathway — an R20-million project scaling to R57.9 million revenue by Year 5 at a 35% EBITDA margin, a 22.4% project IRR, a 28.7% equity IRR and cash payback by month 34.
Plan Contents
This investor-grade business plan is organised into the sections below. Each section is a dedicated page — select any to explore the full detail.
- 1Executive Summary
- 2Company Overview
- 3Industry & Market Analysis
- 4Market & Customer Analysis
- 5Services & Clinical Model
- 6Operations Plan
- 7Marketing & Sales Strategy
- 8Management & Governance
- 9Financial Plan
- 10Risk Management
- 11Regulatory & Compliance Framework
- 12Implementation Roadmap
- 13Strategic Analysis
- 14Exit Strategy
- 15Conclusion
- 16Appendices
Confidentiality & Disclaimer
This Business Plan (the “Plan”) has been prepared by the management
of Renacare Dialysis Clinic (Pty) Ltd (“Renacare” or the “Company”)
solely for the purpose of assisting prospective investors, lenders and
strategic partners in their evaluation of the opportunity described
herein. The Plan contains information that is confidential and
proprietary to the Company.
By accepting this document, the recipient agrees: (i) to keep the
Plan and its contents strictly confidential; (ii) not to reproduce or
distribute any part of the Plan without the prior written consent of the
Company; and (iii) to return or destroy the Plan upon request of the
Company.
The information, estimates and projections contained in this Plan
have been prepared in good faith on the basis of sources believed to be
reliable and on assumptions that management considers reasonable.
However, no representation or warranty, express or implied, is made as
to the accuracy, completeness or correctness of the information
contained in this Plan. Financial projections are forward-looking
statements and are subject to various risks, uncertainties and
assumptions, many of which are beyond the Company’s control. Actual
results may differ materially from those expressed or implied by such
forward-looking statements.
This Plan does not constitute an offer to sell or a solicitation of
an offer to buy any securities. Any such offer or solicitation will be
made only by means of a formal offering document and will be subject to
the terms and conditions set out in that document. Prospective investors
are urged to conduct their own due diligence and to consult with their
own legal, financial, tax and other professional advisors before making
any investment decision.
Chronic kidney disease is a serious, life-threatening medical
condition. Clinical statements made in this Plan are provided for
context only and do not constitute medical advice.
Confidential — this business plan is provided to prospective investors and lenders for evaluation purposes only and may not be reproduced or distributed without the written consent of RenaCare Dialysis Clinic (Pty) Ltd.